News from kintara therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 13, 2021, 08:00 ET Kintara Announces Initiation of Patient Recruitment for VAL-083's Study Arm in the GBM AGILE Trial

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor...


Jan 05, 2021, 08:00 ET Kintara Therapeutics to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor...


Dec 03, 2020, 08:30 ET Kintara Therapeutics to Present at the 2nd Annual Glioblastoma Drug Development Summit

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor...


Nov 19, 2020, 08:00 ET Kintara Therapeutics Reports 10 Months Progression-Free Survival in Newly-Diagnosed MGMT-unmethylated GBM from Ongoing MD Anderson Cancer Center Phase 2 Study

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor...


Nov 13, 2020, 08:00 ET Kintara Therapeutics Announces First Fiscal Quarter 2021 Financial Results and Recent Corporate Updates

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor...


Oct 21, 2020, 08:00 ET Kintara and the Global Coalition for Adaptive Research Execute Agreement for VAL-083's Participation in the GBM AGILE Registrational Study

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor...


Sep 21, 2020, 08:30 ET Kintara Therapeutics Announces Fiscal Year 2020 Financial Results and Recent Corporate Updates

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor...


Sep 01, 2020, 08:30 ET Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million

Kintara Therapeutics, Inc. ("Kintara" or the "Company") (Nasdaq: KTRA) announced today the final closing of its previously announced private...


Aug 26, 2020, 08:30 ET Kintara Therapeutics (formerly DelMar Pharmaceuticals) to Present at the LD Micro 500 Virtual Conference on September 3rd, 2020

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that Saiid Zarrabian,...


Aug 25, 2020, 08:30 ET Kintara Therapeutics Announces Closing of Additional $2.2 Million Private Placement Priced at the Market

Kintara Therapeutics, Inc. ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it has closed its previously announced private placement...


Aug 21, 2020, 08:15 ET Kintara Therapeutics Announces Additional $2.4 Million Private Placement Priced At-The-Market

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it has entered...


Aug 21, 2020, 08:00 ET Kintara Therapeutics (formerly DelMar Pharmaceuticals) Regains Compliance with NASDAQ Minimum Bid Price Requirement

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it has regained...


Aug 20, 2020, 08:30 ET Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market

Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) ("Kintara" or the "Company") (Nasdaq: KTRA) announced today that it has completed...